These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1901836)

  • 41. Prevention of naphthalene-induced cataract and hepatic glutathione loss by the L-cysteine prodrugs, MTCA and PTCA.
    Rathbun WB; Nagasawa HT; Killen CE
    Exp Eye Res; 1996 Apr; 62(4):433-41. PubMed ID: 8795461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical therapy in the prevention of cataract.
    Brown NA; Bron AJ
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhibition effect of epalrestat on rat lens osmotic expansion].
    Ji LX; Shen N; Li CN; Liu Q; Huan Y; Shen ZF
    Yao Xue Xue Bao; 2009 Oct; 44(10):1107-11. PubMed ID: 20055132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of cataract development in severely galactosemic rats by the aldose reductase inhibitor, tolrestat.
    Simard-Duquesne N; Greselin E; Gonzalez R; Dvornik D
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):599-605. PubMed ID: 3983136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.
    Zhang P; Xing K; Randazzo J; Blessing K; Lou MF; Kador PF
    Exp Eye Res; 2012 Aug; 101():36-43. PubMed ID: 22710095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment of a naphthalene cataract model in vitro.
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldose reductase inhibitors from Litchi chinensis Sonn.
    Lee SJ; Park WH; Park SD; Moon HI
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):957-9. PubMed ID: 19555177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
    Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB; Fukui H
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of AL01576 concentration in rat lenses and plasma by bioassay for aldose reductase activity measurements.
    Hockwin O; Müller P; Krolczyk J; McCue BA; Mayer PR
    Ophthalmic Res; 1989; 21(4):285-91. PubMed ID: 2511536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Movement of regenerated lens epithelial cells in 50% galactose cataract and an aldose reductase inhibitor].
    Terubayashi H; Tsuji T; Matumoto Y; Ikebe H; Akagi Y
    Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1044-53. PubMed ID: 2513712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
    Unakar NJ; Tsui JY; Johnson MJ
    J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis).
    Murata M; Ohta N; Sakurai S; Alam S; Tsai J; Kador PF; Sato S
    Chem Biol Interact; 2001 Jan; 130-132(1-3):617-25. PubMed ID: 11306080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.
    Wrobel J; Millen J; Sredy J; Dietrich A; Gorham BJ; Malamas M; Kelly JM; Bauman JG; Harrison MC; Jones LR
    J Med Chem; 1991 Aug; 34(8):2504-20. PubMed ID: 1908522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.